Subcutaneous Tissue (Hypodermis)

Dr. Sarah Chen
PhD, Molecular Biology
The subcutaneous tissue, also known as the hypodermis or subcutis, is the deepest layer of the skin lying beneath the dermis. Composed primarily of adipose (fat) tissue interlaced with connective tissue septa, blood vessels, lymphatics, and nerves, the subcutaneous layer serves critical functions in insulation, energy metabolism, mechanical protection, and structural support . In regenerative dermatology, the subcutaneous tissue is an important target for injectable treatments including PDRN, where its rich vascular supply and cellular composition support therapeutic efficacy.
Anatomy and Composition
Adipose Tissue
The subcutaneous layer is predominantly composed of adipocytes (fat cells) organized into lobules separated by connective tissue septa. These adipocytes store triglycerides as an energy reserve and produce a range of bioactive signaling molecules (adipokines) that influence inflammation, metabolism, and tissue homeostasis .
Connective Tissue Framework
Collagen-rich septa β primarily type I and type III collagen β provide structural support and anchor the subcutaneous layer to the underlying fascia and muscle. These septa also serve as conduits for blood vessels, nerves, and lymphatic channels that traverse the subcutaneous tissue.
Vascular Network
The subcutaneous tissue contains a dense network of arteries, veins, and capillaries that supply both the subcutis and the overlying dermis. The subdermal vascular plexus β located at the junction between the dermis and subcutaneous tissue β is the primary blood supply for the skin and plays a critical role in thermoregulation and nutrient delivery.
Cellular Components
Beyond adipocytes, the subcutaneous tissue contains fibroblasts, macrophages, mast cells, and adipose-derived stem cells (ADSCs). ADSCs are multipotent progenitor cells capable of differentiating into adipocytes, fibroblasts, chondrocytes, and osteoblasts, making them important contributors to tissue repair and regeneration.
Functions of the Subcutaneous Tissue
Insulation and Thermoregulation
The adipose layer provides thermal insulation, reducing heat loss from the body core. Dermal white adipose tissue (dWAT), a specialized adipose depot at the dermal-subcutaneous interface, participates actively in thermogenic responses .
Energy Storage
Subcutaneous adipocytes store and release fatty acids in response to metabolic demands. This energy reserve supports cellular activities throughout the body, including the metabolically active processes of skin repair and regeneration.
Mechanical Protection
The subcutaneous fat layer acts as a shock absorber, cushioning deeper structures β muscles, bones, and internal organs β from external mechanical forces. In the face, subcutaneous fat pads define facial contour and provide the volume that underlies youthful facial architecture.
Structural Support
The subcutaneous tissue anchors the skin to underlying structures while allowing mobility. Age-related changes in subcutaneous fat distribution β atrophy in some areas and redistribution in others β contribute significantly to the visible signs of facial aging.
Endocrine and Paracrine Signaling
Subcutaneous adipocytes produce adipokines including leptin, adiponectin, and various cytokines that influence inflammatory responses, immune function, and the behavior of cells in the overlying dermis .
Age-Related Changes
The subcutaneous tissue undergoes significant changes with aging:
- Volume loss β Progressive atrophy of subcutaneous fat, particularly in the face, hands, and extremities, leading to a hollow, aged appearance
- Redistribution β Fat shifts from the face and extremities to the trunk
- Connective tissue weakening β Collagen septa lose integrity, reducing structural support and allowing fat herniation
- Reduced vascularity β Decreased blood vessel density impairs nutrient delivery to the dermis above
- Stem cell decline β Adipose-derived stem cells decrease in number and regenerative capacity with age
PDRN and the Subcutaneous Tissue
PDRN (polydeoxyribonucleotide) injectable treatments frequently target the subcutaneous tissue and the dermal-subcutaneous interface, leveraging the layer's rich vascular supply and cellular infrastructure :
Injection Depth and Distribution
When PDRN is administered via intradermal or subcutaneous injection, the subdermal vascular plexus facilitates distribution of the active compound. The dense capillary network at the dermal-subcutaneous junction ensures efficient uptake of PDRN fragments by surrounding cells .
Fibroblast Stimulation
PDRN activates fibroblasts within the connective tissue septa of the subcutaneous layer, promoting collagen synthesis and extracellular matrix remodeling. This strengthens the structural framework that supports overlying skin.
Vascular Regeneration
PDRN's pro-angiogenic effects β mediated through adenosine A2A receptor activation and VEGF upregulation β support angiogenesis within the subcutaneous vascular network. Improved vascularity enhances nutrient delivery to both the subcutis and the dermis above.
Anti-Inflammatory Benefits
The subcutaneous tissue can harbor chronic low-grade inflammation, particularly in the context of aging or metabolic dysfunction. PDRN's anti-inflammatory action helps resolve this subcutaneous inflammation, creating a tissue environment more conducive to regeneration and repair.
Tissue Regeneration Support
By providing nucleotide building blocks through the salvage pathway, PDRN supports the proliferative demands of adipose-derived stem cells and fibroblasts within the subcutaneous tissue, enhancing the layer's intrinsic regenerative capacity .
Related Concepts
- Extracellular Matrix β The structural framework within connective tissue septa of the subcutis
- Fibroblast β Key structural cell within the subcutaneous connective tissue
- Collagen Types β The collagens that form the connective tissue septa
- Angiogenesis β Vascular regeneration within the subcutaneous tissue
- Tissue Regeneration β The broader repair process supported by subcutaneous cellular infrastructure
References
- [1]Driskell RR, Jahoda CA, Chuong CM, Watt FM, Horsley V. Defining dermal adipose tissue. Exp Dermatol. 2014;23(9):629-631. doi:10.1111/exd.12450
- [2]Kruglikov IL, Scherer PE. Dermal adipocytes: from irrelevance to metabolic targets?. Trends Endocrinol Metab. 2016;27(1):1-10. doi:10.1016/j.tem.2015.11.002
- [3]Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
- [4]Salti G, Rauso R. Facial rejuvenation with PDRN: a retrospective clinical evaluation. J Cosmet Dermatol. 2020;19(10):2573-2577. doi:10.1111/jocd.13305
- [5]Alexander CM, Kasza I, Yen CLE, et al.. Dermal white adipose tissue: a new component of the thermogenic response. J Lipid Res. 2015;56(11):2061-2069. doi:10.1194/jlr.R062893